Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid Solutions for Trigger Finger
NCT04002037Phase 4Terminated
- Sponsor
- University of Missouri
- Start
- Jun 2019
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide in trigger finger, sponsored by University of Missouri. Started Jun 2019; status: terminated.
02
Drugs
triamcinolone acetonide
03
Conditions
trigger finger
Beyond the preview
Go deeper on NCT04002037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04002037.